Funders › UT › The Cholangiocarcinoma Foundation › 2025
Grants paid by The Cholangiocarcinoma Foundation, tax year 2025
EIN 20-5776861 · Salt Lake City, UT · Form 990, Schedule I · NTEE H99
In tax year 2025, The Cholangiocarcinoma Foundation (EIN 20-5776861) reported 7 grants paid totaling $820,000. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2025
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2025 | Mayo Clinic Rochester, MN | A | $245,000 | paid | CANCER RESEARCH | 202630289349300613 |
| 2025 | Ucsf San Francisco, CA | A | $185,000 | paid | CANCER RESEARCH | 202630289349300613 |
| 2025 | Vanderbilt Nashville, TN | A | $130,000 | paid | CANCER RESEARCH | 202630289349300613 |
| 2025 | Mass General Hospital Boston, MA | A | $65,000 | paid | CANCER RESEARCH | 202630289349300613 |
| 2025 | National Cancer Institute Bethesda, MD | A | $65,000 | paid | CANCER RESEARCH | 202630289349300613 |
| 2025 | Md Anderson Cancer Center Houston, TX | A | $65,000 | paid | CANCER RESEARCH | 202630289349300613 |
| 2025 | Beth Israel Deaconess Medical Cente Boston, MA | A | $65,000 | paid | CANCER RESEARCH | 202630289349300613 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.